The National Australian HCV Point-of-Care Testing Program - HCV Antibody Testing Minimal Dataset

This is an observational cohort study. Participants will be recruited from settings that provide services to people with a risk factor for the acquisition of HCV infection. Participants will attend a single visit to have HCV point-of-care testing. Participants who have not previously received HCV treatment will have a point-of-care HCV antibody test, followed by reflex point-of-care HCV RNA test if positive. Those who have a history of HCV treatment will proceed straight to point-of-care HCV RNA testing. Participants will not receive treatment as a part of this study. Participants who are HCV RNA positive will receive treatment via standard of care. The purpose of this study is to look at the effect of finger-stick point-of-care hepatitis C testing, to see if it increases the number of tests, diagnoses, and treatments for people with a risk factor of having hepatitis C in Australia.

Inclusion Criteria:Provide informed consent≥ 18 years of age.Exclusion Criteria:Is unable or unwilling to provide informed consent